GANDALF: Generative Adversarial Networks with Discriminator-Adaptive
  Loss Fine-tuning for Alzheimer's Disease Diagnosis from MRI by Shin, Hoo-Chang et al.
GANDALF: Generative Adversarial Networks
with Discriminator-Adaptive Loss Fine-tuning
for Alzheimer’s Disease Diagnosis from MRI
Hoo-Chang Shin1, Alvin Ihsani1, Ziyue Xu1, Swetha Mandava1, Sharath
Turuvekere Sreenivas1, Christopher Forster1, Jiook Cha2
and Alzheimer’s Disease Neuroimaging Initiative
1 NVIDIA Corporation; hshin@nvidia.com
2 Department of Psychology, Center for REAL Intelligence, AI Institute, Seoul
National University; connectome@snu.ac.kr
Abstract. Positron Emission Tomography (PET) is now regarded as
the gold standard for the diagnosis of Alzheimer’s Disease (AD). How-
ever, PET imaging can be prohibitive in terms of cost and planning, and
is also among the imaging techniques with the highest dosage of radi-
ation. Magnetic Resonance Imaging (MRI), in contrast, is more widely
available and provides more flexibility when setting the desired image
resolution.
Unfortunately, the diagnosis of AD using MRI is difficult due to the very
subtle physiological differences between healthy and AD subjects visible
on MRI. As a result, many attempts have been made to synthesize PET
images from MR images using generative adversarial networks (GANs)
in the interest of enabling the diagnosis of AD from MR. Existing work
on PET synthesis from MRI has largely focused on Conditional GANs,
where MR images are used to generate PET images and subsequently
used for AD diagnosis. There is no end-to-end training goal.
This paper proposes an alternative approach to the aforementioned,
where AD diagnosis is incorporated in the GAN training objective to
achieve the best AD classification performance. Different GAN losses
are fine-tuned based on the discriminator performance, and the overall
training is stabilized. The proposed network architecture and training
regime show state-of-the-art performance for three- and four- class AD
classification tasks.
Keywords: Alzheimer Disease · Neuroimaging · Generative Models
1 Introduction
1.1 PET Imaging and AD Diagnosis
Alzheimer’s Disease (AD) is the most common cause of dementia, affecting qual-
ity of life for many elderly people and their families. Early diagnosis and interven-
tion of AD can improve the quality of life by significantly slowing the progression
ar
X
iv
:2
00
8.
04
39
6v
1 
 [e
es
s.I
V]
  1
0 A
ug
 20
20
2 Shin et al.
of the disease, thus it is an active area of research. Positron Emission Tomog-
raphy (PET) appears to be a very promising imaging technique to assess the
progression and stage of the disease by monitoring the spread of Tau-protein in
the form of Neurofibrillary Tangles (NFT) and Amyloid beta (Aβ) [12,13,21].
As a functional imaging technique, PET uses a radioactive tracer injected into
the patient, and images the distribution of the tracer over the course of min-
utes or hours. In AD research, PET imaging techniques measure amyloid plaque
(AV45) [4,22] and tau protein aggregates (AV1451) [17,24] that are essential
to understanding AD pathology and diagnosis. Compared to AV45-/AV1451-
PET, FDG-PET usually helps differentiate AD from other causes of demen-
tia, because it can characterize the patterns of glucose metabolism in the brain
that are specific to AD [16]. Example T1-weighted Magnetic Resonance images,
AV45-/FDG- PET brain images of CN and AD are shown in Figure 1.
Fig. 1. Examples of T1-weighted MRI, AV45-PET, FDG-PET brain images of Cogni-
tive Normal (CN), early mild cognitive impairment (EMCI), and Alzheimer’s disease
(AD). The differences are much more clearly visible on the PET images than in the MR
images, especially for the EMCI case. On the EMCI case, increased accumulation of
AV45 in the medial temporal, occipital, and frontal lobe (inferior frontal gyrus shown)
is noticeable. AD shows reduced brain metabolism in the FDG scan, and significant
uptake of AV45 compared to both CN and EMCI due to widespread accumulation
of Amyloid-β. In the T1-weighted MRI images, the size increment of the ventricles is
visible from CN to EMCI to AD, however it is not as clearly visible as in PET.
While PET plays an important role for AD diagnosis, it can be prohibitive
in terms of cost and planning: (1) the short half life of the radioisotopes requires
on-site production in remote regions; (2) no-show patients result in radioisotopes
being wasted; (3) the length of imaging sessions is determined by the tracer and
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the use case so motion artifacts may be unavoidable, and lastly; (4) small varia-
tions (∼5 min) in the acquisition start time may cause over- or under-estimation
of quantitative parameters. It is also not as widely available as Magnetic Reso-
nance Imaging (MRI).
1.2 Synthesizing PET Images from MR for AD Diagnosis
To address the shortcomings of PET for AD diagnosis, a number of studies
have attempted AD diagnosis from T1-weighted MR images. While T1-weighted
MRI is most suitable for visualizing anatomical structures in the brain, it is not
optimal for AD diagnosis because it does not highlight functional or metabolic
properties of brain tissues. The question arises as to whether one can leverage
existing combined PET-MR image pairs (a combined imaging modality available
to only large research institutions) to generate PET images from MR-only image
acquisitions.
Conditional generative adversarial networks (CGAN) [11] have previously
been used to generate images of a modality from a paired input image of a
different modality. Frequent examples of such paired images are images and
label maps, images and sketch, and pictures of the same scene from one lighting
condition to another (e.g. day/night). For medical image analysis, such as AD
diagnosis, PET image is generated from MRI using CGAN. The generated PET
is then used to train AD classification network.
This work proposes an approach similar to CGAN, where CGAN is trained
end-to-end with the final goal of AD classification. If trained with classification
goal, then the performance of generating realistic images may be compromised.
We overcome this limitation by adaptively fine-tuning the GAN losses and classi-
fication losses. Also, the overall GAN training is stabilized by the loss fine-tuning.
State-of-the-art result on three- and four- class AD classification are achieved
with the proposed architecture and training regime.
1.3 Dataset and Classification of Cognitive Decline
We use the publicly available ADNI (Alzheimers Disease Neuroimaging Initia-
tive) dataset comprised of F18-AV-45 (florbetapir) and F18-FDG (fluorodeoxyglu-
cose) PET image pairs along with the co-registered T1-weighted MRI. The
dataset contains six dementia related conditions: cognitive normal (CN), early
mild cognitive impairment (EMCI), late mild cognitive impairment (LMCI),
mild cognitive impairment (MCI), subjective memory complaint (SMC), and
Alzheimer disease (AD). Among these conditions, SMC is difficult to subjec-
tively distinguish from CN. Also, there may be overlaps between EMCI/LMCI
and MCI. Therefore, we test binary classification of AD/CN, three- and four-
class classification of AD/MCI/CN and AD/LMCI/EMCI/CN for early AD di-
agnosis. Figure 1 show some examples of CN, EMCI, AD images in the dataset.
We randomly divide the dataset with 70% training, 10% validation, and
20% testing according to the patients, resulting 722/104/207 subjects for each
train/validation/test set. Some subjects have multiple scans (i.e., more than one
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temporal scan), with the total 1,525 image triplets (AD45-/FDG-PET, T1-MRI).
The images are pre-processed using FreeSurfer [1]. The T1-weighted images are
skull-stripped, where non-cerebral matters such as skull and scalp are removed.
Registration, re-scaling [9] and partial volume correction [8] is applied to the
PET images. The T1-weigthed images are re-scaled to 1mm3 with 2563 voxels,
and PET images are 2× 93× 76× 76 voxels with 2 temporal resolution.
2 Related Works
Image-based AD diagnosis is regarded as a challenging task. Most of the prior
works use a combination of structural and functional imaging, such as T1-
weighted MRI and PET, or T1-weighted MRI and functional MRI such as DTI
(diffusion tensor imaging). They also typically focus on binary classification of
each state category, such as AD vs. NC, or AD vs. MCI.
A combination of T1-weighted MRI, AV45-/FDG-PET was used with multi-
feature kernel supervised within-class-similar discriminative dictionary learning
algorithm to demonstrate binary classification of AD/NC, MCI/NC, AD/MCI in
[15]. A combination of T1-weighted MRI and FDG-PET with three-dimensional
convolutional neural network (CNN) was used to demonstrate binary classifi-
cation of CN/AD, CN/pMCI, sMCI/pMCI in [10]. GAN was used to generate
additional PET images from T1-weighted MRI that do not have AV45-PET im-
age pairs in [25]. MRI and real-/synthetic- PET image pairs are subsequently
used to train CNN to perform binary classification of stable-MCI/progressive-
MCI.
Functional MRI (fMRI) is an MRI imaging technique most similar to PET
that it can measure brain activity by detecting changes associated with blood
flow. A minimum spanning tree (MST) classification framework was proposed
in [5] to perform binary classification of MCI/NC, AD/CN, and AD/MCI using
fMRI. A combination of T1-weighted MRI and Diffusion Tensor Imaging (DTI)
was used with Multiple Kernel Learning to demonstrate binary classification of
CN/AD, CN/MCI, AD/MCI in [2].
More recent work demonstrates diagnosing AD from T1-weighted MRI only.
Longitudinal studies with landmark-based features and support vector machines
to classify CN/AD and CN/MCI in [26]. T1-weighted MRI was used with convo-
lutional autoencoder based unsupervised learning for the CN/AD and progressive-
MCI/stable-MCI classification task in [18]. Other recent works show multi-class
classification using T1-weighted MRI. A variant of DenseNet CNN was used for
multi-class classification of AD/MCI/NC using MRI in [23]. T1-weighted MRI
was used with CNN to demonstrate binary classification of NC/AD and three-
class classification of NC/AD/MCI in [6].
3 Methods
The pix2pix [11] CGAN architecture is widely adopted in the medical image
analysis domain for synthesizing from one image modality to another. For in-
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stance, Yan et. al [25] use the CGAN to generate AV45-PET from T1-weighted
MRI to supplement the training dataset with additional synthetic PET-MRI
image pairs. While for generating an image of different modality may be an end-
goal for computer vision domain, in medical domain we often want to diagnose
a disease, such as AD, using the generated image. We hypothesize that a GAN
designed and trained with this diagnosis end-goal in mind can outperform in AD
diagnosis, compared to other types of CGAN application where synthesis and
diagnosis are trained separately.
3.1 Conditional Generative Adversarial Networks
The pix2pix [11] CGAN is trained with the following objective:
G∗ = arg min
G
max
D
LcGAN (G,D) + λLL1(G). (1)
where LcGAN (G,D) and and LL1(G) are defined as
LcGAN (G,D) =Ex,y[logD(x, y)] + Ex,z[log(1−D(x,G(x, z))], (2)
LL1(G) =Ex,y,z[‖y −G(x, z)‖1]. (3)
where x, y and G(x, z) can be regarded as MRI, PET input, and generated PET.
The CGAN consists of a generator (G) that has encoder-decoder architecture,
and a discriminator (D) that is a CNN classifier. The U-Net [19] architecture is
usually used as the G that takes an input image and generates an output image of
a same size but of different modality or characteristics. PET conventionally has
lower image resolution than MRI, so we modify the U-Net architecture to take
the different resolutions into account - MRI: 256×256×256; PET: 2×93×76×76.
The encoder part has eight layers while the decoder part has five. Only the middle
five layers in the encoder-decoder part has the skip-connection, with the last two
up-sampling (transpose convolution) layers to make the target PET resolution.
The discriminator CNN has three convolutional (conv-) layers that take MRI
input, and two conv-layers that take PET input. The two branches of conv-
layers are merged and followed by two additional conv-layers for classification.
3.2 GAN with Discriminator-Adaptive Loss Fine-tuning
GAN is trained with minimax objective [7] where G and D compete with each
other. CGAN is trained with an additional L1 loss for the G, and a patch-
GAN [11] classifier for the D. The D in our generative network is trained with
additional AD classification losses: (1) based on real MRI and generated PET
input, multiplied by a hyper-parameter λGAND , and (2) based on real MRI and
PET, multiplied by λCLSD :
LD(D,G) =λGAND arg min
G
LcGAN (G,D) + λCLSDEx,y,yˆ[logD(yˆ|x, y)], (4)
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Fig. 2. Overall architecture and training pipeline. While generator and discriminator
are trained independently to compete against each other, they are both trained with
the additional AD classification loss that are adjusted (1) to generate realistic PET
images, and (2) to perform well on AD classification. In addition, losses are monitored
and weights are adjusted to stablilize the GAN training, preventing loss oscillation.
where yˆ is the AD label.
The G is also trained with AD classification loss based on real MRI and
generated PET input, in addition to the GAN loss and L1 loss. Each loss is
multiplied with hyper-parameters to control their relative importance during
the training - λCLSG , λGANG , and λL1:
LG(G,D) =λGANG arg max
D
LcGAN (G,D)+
λCLSGEx,yˆ[logD(yˆ|x,G(x, z))] + λL1LL1(G). (5)
In the earlier phase of the GAN training, generated PET likely are far from
the real ones. They progressively become more realistic as the training proceeds.
Therefore, D is trained initially with small λGAND and gradually increased dur-
ing the training, while λCLSD starts from a larger value and gradually decreased.
This encourages the D to focus on AD classification when G is improving to gen-
erate more realistic PET images. The G is trained with a large λGANG at first
so it can focus on generating realistic PET in the beginning. It is gradually de-
creased as λCLSG increases from a smaller value, to emphasize AD classification
using the generated PET images. We set λGAND and λCLSG as 0.01 and linearly
increase 10 times per epoch, λCLSD and λGANG initially as 100 and decrease
1/10 times per epoch. We train for 1000 epochs using ADAM optimizer [14].
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Stabilizing Training Training D and G independently, the D and G loss
can oscillate rather than being in a stable convergence state [3]. To remedy
this problem we continuously monitor the D and G loss, and adjust the hyper-
parameters λ for the losses if any one is lower compared to the previous epoch.
Loss oscillation generally occurs when the training has well proceeded, and this is
when AD classification losses get higher weights. This is similar to the approach
of [20] penalizing D weights with annealing to stabilize the GAN training. For
example, when the D loss starts to oscillate and becomes higher compared to
the previous epoch, then (1) its previous checkpoint is restored, and (2) λCLSD
gets decreased. The overall training pipeline is shown in Figure 2.
4 Results
We perform two- to four- class AD classification using T1-weighted MRI in-
put. The two-class AD classification results is shown in Table 1. The CNN ap-
proach in [6] report better performance on the two-class AD/CN classification,
and GANDALF show similar performance to pix2pix + CNN method. We suspect
this may be because AD vs. CN is more clearly visible than AD/MCI/CN or
AD/LMCI/EMCI/CN on MRI, so a deep CNN with good hyper-parameter set
can provide better result and PET plays a rather limited role for the diagno-
sis. We did not conduct a thorough hyper-parameter search for GANDALF in this
study.
Table 1. Comparison of MRI-based AD diagnosis for AD vs. CN binary classification.
CNN based method [6] reports best performance which may indicate using PET and
synthesized PET is more useful for early AD diagnosis.
Method AD/CN Acc F2 Prec Rec
Esmaeilzadeh et.al [6] 200/230 94.1 0.93 0.92 0.94
pix2pix + CNN 162/428 85.2 0.83 0.84 0.83
GANDALF 162/428 85.2 0.84 0.84 0.84
Results of the three-class AD/MCI/CN classification task are shown in Ta-
ble 2. We achieve state-of-the-art performance on the three-class classification
compared to the prior works using T1-weighted MRI input. MCI may show more
subtle difference on the MRI compared to the AD as can be seen in Figure 1.
This, and the consistent better performance of the generative methods compared
to the prior works could indicate that an additional training of synthesizing PET
can help achieving better performance for early AD diagnosis.
Lastly, four-class classification of AD/LMCI/EMCI/CN results are shown in
Table 3. We show a meaningful first result on classifying early-MCI and late-MCI
from CN and AD, a promising first step for early AD diagnosis using T1-weighted
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Table 2. MRI-based AD diagnosis for AD/MCI/CN three-class classification. Better
performance shown by generative methods may suggest additional training to generate
synthesized PET can be promising for early diagnosis of AD using MRI.
Method AD/MCI/CN Acc F2 Prec Rec
Esmaeilzadeh et.al [6] 200/411/230 61.1 0.62 0.59 0.63
Wu et.al [23] 130/455/200 N/A 0.49 0.62 0.35
pix2pix + CNN 162/456/428 71.3 0.63 0.64 0.63
GANDALF 162/456/428 78.7 0.69 0.83 0.66
MRI. Our proposed GANDALF method also shows improved performance com-
pared to the pix2pix + CNN method. Towards the end of the GANDALF training,
the entire network acts as a classification network with T1-weighted MRI input.
Finding a better/deeper classifier/discriminator architecture could improve the
final classification performance. However this should be balanced with the gen-
erator architecture/depth for the GAN training with the minimax objective. A
thorough hyper-parameter search could also improve the final performance.
Table 3. MRI-based AD diagnosis for AD/LMCI/EMCI/CN four-class classification.
We show meaningful result that can be promising for early diagnosis on AD using
T1-weighted MRI input.
Method AD/LMCI/EMCI/CN Acc F2 Prec Rec
pix2pix + CNN 162/456/219/428 33.0 0.34 0.34 0.34
GANDALF 162/456/219/428 37.0 0.40 0.39 0.40
5 Conclusion
Early diagnosis and intervention of Alzheimer’s disease (AD) can significantly
slow the progression of the disease and improve patients’ condition and the life
quality of the patient and their caregivers. PET imaging can provide great in-
sight for early diagnosis of AD, however, it is rarely available outside of research
environments. Earlier works on MRI-based AD diagnosis use conditional genera-
tive adversarial networks (GAN) to synthesize PET from MRI, and subsequently
use the generated PET for AD diagnosis.
We propose a network where AD diagnosis end-goal is incorporated into the
MRI-PET synthesis and trained end-to-end, instead of first synthesizing PET
and then use it for AD diagnosis. Furthermore, we suggest a training scheme
to stabilize the GAN training. We achieve state-of-the-art MRI-based AD di-
agnosis for three-class AD classification of AD/MCI/CN. We also achieve the
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first meaningful result on four-class (AD/LMCI/EMCI/CN) classification that
can be promising for early diagnosis of AD based on MRI, to the best of our
knowledge.
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